131 related articles for article (PubMed ID: 17180738)
1. Use of the University of California Los Angeles Integrated Staging System (UISS) to predict survival in localized renal cell carcinoma in an Asian population.
Ng CF; Wan SH; Wong A; Lai FM; Hui P; Cheng CW
Int Urol Nephrol; 2007; 39(3):699-703. PubMed ID: 17180738
[TBL] [Abstract][Full Text] [Related]
2. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
Patard JJ; Kim HL; Lam JS; Dorey FJ; Pantuck AJ; Zisman A; Ficarra V; Han KR; Cindolo L; De La Taille A; Tostain J; Artibani W; Dinney CP; Wood CG; Swanson DA; Abbou CC; Lobel B; Mulders PF; Chopin DK; Figlin RA; Belldegrun AS
J Clin Oncol; 2004 Aug; 22(16):3316-22. PubMed ID: 15310775
[TBL] [Abstract][Full Text] [Related]
3. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
4. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
5. [External validation of the University of Los Angeles Integrated Staging System (UISS) in localized renal cell carcinoma: single center study].
Onea C; Mouracade P; Roman H; Wagner B; Saussine C; Jacqmin D; Lang H
Prog Urol; 2010 Jan; 20(1):35-9. PubMed ID: 20123526
[TBL] [Abstract][Full Text] [Related]
6. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
Antonelli A; Cozzoli A; Zani D; Zanotelli T; Nicolai M; Cunico SC; Simeone C
BJU Int; 2007 Feb; 99(2):296-300. PubMed ID: 17326263
[TBL] [Abstract][Full Text] [Related]
7. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
8. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
[TBL] [Abstract][Full Text] [Related]
9. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
[TBL] [Abstract][Full Text] [Related]
10. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy.
Cindolo L; Chiodini P; Gallo C; Ficarra V; Schips L; Tostain J; de La Taille A; Artibani W; Patard JJ
Cancer; 2008 Jul; 113(1):65-71. PubMed ID: 18473356
[TBL] [Abstract][Full Text] [Related]
11. Improved prognostication of renal cell carcinoma using an integrated staging system.
Zisman A; Pantuck AJ; Dorey F; Said JW; Shvarts O; Quintana D; Gitlitz BJ; deKernion JB; Figlin RA; Belldegrun AS
J Clin Oncol; 2001 Mar; 19(6):1649-57. PubMed ID: 11250993
[TBL] [Abstract][Full Text] [Related]
12. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.
Han KR; Bleumer I; Pantuck AJ; Kim HL; Dorey FJ; Janzen NK; Zisman A; Dinney CP; Wood CG; Swanson DA; Said JW; Figlin RA; Mulders PF; Belldegrun AS
J Urol; 2003 Dec; 170(6 Pt 1):2221-4. PubMed ID: 14634383
[TBL] [Abstract][Full Text] [Related]
13. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
[TBL] [Abstract][Full Text] [Related]
15. Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma.
Kroeger N; Lebacle C; Hein J; Rao PN; Nejati R; Wei S; Burchardt M; Drakaki A; Strother M; Kutikov A; Uzzo R; Pantuck AJ
Eur J Cancer; 2022 Jun; 168():68-76. PubMed ID: 35461012
[TBL] [Abstract][Full Text] [Related]
16. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.
Yang G; Nie P; Yan L; Zhang M; Wang Y; Zhao L; Li M; Xie F; Xie H; Li X; Xiang F; Wang N; Cheng N; Zhao X; Wang N; Wang Y; Chen C; Yun C; Cui J; Duan S; Zhang R; Hao D; Wang X; Wang Z; Niu H
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2949-2959. PubMed ID: 35344062
[TBL] [Abstract][Full Text] [Related]
17. Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.
May M; Brookman-Amissah S; Kendel F; Knoll N; Roigas J; Hoschke B; Miller K; Gilfrich C; Pflanz S; Gralla O
Int J Urol; 2009 Jul; 16(7):616-21. PubMed ID: 19456988
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
Belldegrun A; Tsui KH; deKernion JB; Smith RB
J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
[TBL] [Abstract][Full Text] [Related]
20. ST6Gal-I predicts postoperative clinical outcome for patients with localized clear-cell renal cell carcinoma.
Liu HO; Wu Q; Liu WS; Liu YD; Fu Q; Zhang WJ; Xu L; Xu JJ
Asian Pac J Cancer Prev; 2014; 15(23):10217-23. PubMed ID: 25556450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
